Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Safety evaluation of intra-arterial cell delivery in stroke patients—a framework for future trials

Tools
- Tools
+ Tools

Boltze, Johannes and Jolkkonen, Jukka (2019) Safety evaluation of intra-arterial cell delivery in stroke patients—a framework for future trials. Annals of Translational Medicine, 7 (S8). S271. doi:10.21037/atm.2019.12.07

[img]
Preview
PDF
WRAP-safely-evaluation-intra-arterial-cell-Boltze-2019.pdf - Published Version - Requires a PDF viewer.

Download (677Kb) | Preview
Official URL: http://dx.doi.org/10.21037/atm.2019.12.07

Request Changes to record.

Abstract

Effective treatments are not yet available for the majority of stroke patients despite the significant advances in acute stroke management and care evident since the advent of therapeutic recanalization in 2015. Unfortunately, even patients who are eligible for recanalization treatment often suffer from residual functional deficits. Hence, there is an unmet demand for additional stroke therapies promoting functional recovery, not only those that can be considered as complementary approaches to recanalization but also for treatments that can be provided beyond its narrow time window. Cell therapies are an emerging paradigm in translational neuroscience and have been widely investigated in experimental stroke models (1). Preclinical evidence collected over the past two decades has revealed that administration of cells can exert robust effects in improving functional outcome when delivered in subacute (2,3) and even in chronic stroke stages (4). These promising findings have promoted small, early phase clinical studies intended to assess the feasibility, safety and efficacy of cell therapy approaches (5).

Item Type: Journal Item
Subjects: Q Science > QH Natural history
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- )
Library of Congress Subject Headings (LCSH): Cerebrovascular disease , Cerebrovascular disease -- Patients , Cerebrovascular disease -- Patients -- Rehabilitation, Cellular therapy , Stem cells -- Therapeutic use
Journal or Publication Title: Annals of Translational Medicine
Publisher: Society for Translational Medicine (STM), Hong Kong
ISSN: 2305-5839
Official Date: December 2019
Dates:
DateEvent
December 2019Available
29 November 2019Accepted
Volume: 7
Number: S8
Article Number: S271
DOI: 10.21037/atm.2019.12.07
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 10 January 2020
Date of first compliant Open Access: 13 January 2020

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us